Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Harmony Biosciences Holdings Inc shares valued at $787,378 were sold by Kapadia Sandip on Aug 15 ’25. At $36.50 per share, Kapadia Sandip sold 21,573 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, SANDIP KAPADIA purchased 21,573 shares, netting a total of over 787,630 in proceeds.
Before that, JEFFREY G DIERKS had added 5,615 shares to its account. In a trade valued at $202,009, the Former Officer bought Harmony Biosciences Holdings Inc shares for $35.98 each.
As published in their initiating research note from Truist on July 21, 2025, Harmony Biosciences Holdings Inc [HRMY] has been a Buy and the price target has been revised to $48. Earlier on February 11, 2025, Deutsche Bank initiated its rating. Their recommendation was “a Buy” for HRMY stock.
Analyzing HRMY Stock Performance
On last trading session, Harmony Biosciences Holdings Inc [NASDAQ: HRMY] rose 0.63% to $33.42. The stock’s lowest price that day was $33.24, but it reached a high of $33.76 in the same session. During the last five days, there has been a drop of approximately -7.93%. Over the course of the year, Harmony Biosciences Holdings Inc shares have dropped approximately -9.41%. Shares of the company reached a 52-week high of $40.93 on 01/21/25 and a 52-week low of $26.47 on 04/09/25.
Support And Resistance Levels for Harmony Biosciences Holdings Inc (HRMY)
According to the 24-hour chart, there is a support level at 33.19, which, if violated, would cause prices to drop to 32.95. In the upper region, resistance lies at 33.71. The next price resistance is at 33.99. RSI (Relative Strength Index) is 34.42 on the 14-day chart, showing neutral technical sentiment.
Is Harmony Biosciences Holdings Inc subject to short interest?
Stocks of Harmony Biosciences Holdings Inc saw a sharp rise in short interest on 2025-08-29 jumping by 0.11 million shares to 4.33 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 4.22 million shares. A jump of 2.53% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 8.35 of the overall float, the days-to-cover ratio (short ratio) jumped to 8.35.
Which companies own the most shares of Harmony Biosciences Holdings Inc (HRMY)?
In terms of Harmony Biosciences Holdings Inc share price expectations, FactSet research, analysts set an average price target of 40.5 in the next 12 months, up nearly 21.95% from the previous closing price of $33.21. Analysts anticipate Harmony Biosciences Holdings Inc stock to reach 48 by 2025, with the lowest price target being 33. In spite of this, 6 analysts ranked Harmony Biosciences Holdings Inc stock as Buy at the end of 2025. On December 17, 2024, H.C. Wainwright assigned a price target of “a Buy” to the stock and initiated coverage with a $75.
